Roche presents new data from multiple Phase III studies of Tecentriq in triple-negative breast cancer at ESMO Virtual Congress 2020GlobeNewsWire • 09/19/20
Genentech Presents New Data From Multiple Phase III Studies of Tecentriq in Triple-Negative Breast Cancer at ESMO Virtual Congress 2020Business Wire • 09/19/20
Roche says its Actemra drug reduces the severity of COVID-19 in hospitalised patientsInvezz • 09/18/20
Roche receives positive CHMP opinion for Tecentriq in combination with Avastin for the treatment of people with the most common form of liver cancerGlobeNewsWire • 09/18/20
Shares of Roche gain as it says arthritis drug can lessen need for ventilators in COVID-19 patientsMarket Watch • 09/18/20
Roche launches new quantitative antibody test to measure SARS-CoV-2 antibodies, to support the evaluation of vaccinesGlobeNewsWire • 09/18/20
Roche’s phase III EMPACTA study showed Actemra/RoActemra reduced the likelihood of needing mechanical ventilation in hospitalised patients with COVID-19 associated pneumoniaGlobeNewsWire • 09/18/20
Roche to present a broad range of data across multiple cancer types at the ESMO Virtual Congress 2020GlobeNewsWire • 09/17/20
Roche receives FDA approval for expanded use of the CINtec PLUS Cytology test to aid clinicians in preventing cervical cancerGlobeNewsWire • 09/16/20
New data further reinforce Roche’s OCREVUS (ocrelizumab) as a highly effective treatment for people with multiple sclerosisGlobeNewsWire • 09/11/20
New data show Roche’s ENSPRYNG (satralizumab) significantly reduces severity and risk of relapse in neuromyelitis optica spectrum disorder (NMOSD)GlobeNewsWire • 09/10/20
Roche expands its multiple sclerosis portfolio with investigational BTK inhibitor fenebrutinib and initiates novel clinical trials for OCREVUS (ocrelizumab)GlobeNewsWire • 09/09/20
Roche receives FDA clearance for BK virus quantitative test on cobas 6800/8800 Systems to support better care for transplant patientsGlobeNewsWire • 09/08/20
Roche announces FDA approval of Gavreto (pralsetinib) for the treatment of adults with metastatic RET fusion-positive non-small cell lung cancerGlobeNewsWire • 09/07/20
Roche receives FDA Emergency Use Authorization for the cobas SARS-CoV-2 & Influenza A/B Test for use on the cobas 6800/8800 SystemsGlobeNewsWire • 09/04/20